Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

190.01
+1.070.57%
Post-market: 189.64-0.3700-0.19%19:59 EDT
Volume:10.29M
Turnover:1.94B
Market Cap:75.86B
PE:-23.73
High:193.72
Open:190.26
Low:183.28
Close:188.94
52wk High:208.90
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.67
T/O Rate:2.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:11.22
PE(LYR):-26.17

Loading ...

Moderately bullish activity in Moderna with shares up 11.44%

TIPRANKS
·
Aug 25

Moderna Raised to Peer Perform from Underperform by Wolfe Research

Dow Jones
·
Aug 25

What Happens if Moderna's Cancer Vaccine Works

Dow Jones
·
Aug 25

Market Movers | Bloom Energy Rises on Pelosi Buy; Nebius, NetEase Gain on Goldman Calls; Moderna Rallies

Tiger Newspress
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Moderna on Track for Best Month on Record

Dow Jones
·
Aug 25

Early notable gainers among liquid option names on August 25th

TIPRANKS
·
Aug 25

Moderna Shares up 8.4% as Barclays Hikes Price Target

THOMSON REUTERS
·
Aug 25

Movement Alert|Moderna, Inc. Rises 4.3% in Regular Trading, Continued Price Reassessment After Cancer Vaccine Phase III Success

Market Focus
·
Aug 25

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Chip Stocks Recover

MT Newswires Live
·
Aug 25

After Moderna’s $44B Oncology Win, Silexion’s Pancreatic Cancer Treatment is Worth Exploring (NASDAQ: SLXN)

TIPRANKS
·
Aug 25

Moderna upgraded to Peer Perform from Underperform at Wolfe Research

TIPRANKS
·
Aug 25

Movement Alert|Moderna, Inc. Rises 3.99% in Pre-Market Trading, Continues Volatile Re-Rating After mRNA Cancer Vaccine Phase III Success

Market Focus
·
Aug 25

Binance launches 5 stock perpetuals with 20x leverage

cryptonews
·
Aug 25

Moderna's Landmark mRNA Cancer Vaccine Trial Success Ignites Biotech Sector Rally, Valuation Reset May Be Just Beginning

Stock News
·
Aug 25

Moderna Inc. Stock Slides 4.3%, Underperforms Peers

Dow Jones
·
Aug 25

Moderna (MRNA) Stock Looks Above Fair Value On Sales But Strong On Returns

Simply Wall St.
·
Aug 25

Moderna Inc Stock (MRNA) Moved Down by 5.13% on Aug 24: A Full Analysis

TradingKey
·
Aug 25

Moderna is Betting Big on Its Cancer Vaccine. This is What Wall Street Wants to See.

Dow Jones
·
Aug 24

Movement Alert|Moderna, Inc. Falls 5.65% in Regular Trading, Continued Repricing Volatility After mRNA Cancer Vaccine Phase III Breakthrough

Market Focus
·
Aug 24